Facebook PixelEngineer cells of the immune system that indiscriminately deliver nucleic acid payloads
Brainstorming
Tour
Brainstorming
Create newCreate new
EverythingEverything
ChallengesChallenges
IdeasIdeas
Idea

Engineer cells of the immune system that indiscriminately deliver nucleic acid payloads

Image credit: Euthman

Loading...
Darko Savic
Darko Savic Feb 25, 2021
Please leave the feedback on this idea
Originality

Is it original or innovative?

Feasibility

Is it feasible?

Necessity

Is it targeting an unsolved problem?

Conciseness

Is it concisely described?

Bounty for the best solution

Provide a bounty for the best solution

Bounties attract serious brainpower to the challenge.

Currency *
Bitcoin
Who gets the Bounty *
Distribution
This could be used as a way to seek and destroy hardy parasites (for example Leishmania) or bacteria that evade the immune system (like H. Pylori). It could also be used to deliver organism-wide gene therapies without encountering resistance from the immune system.

We would take a suitable type of innate immune system cell (possibly neutrophils, macrophages, or NK cells) and engineer it to indiscriminately deliver nucleic acid payloads into any type of cell it encounters - be it human or pathogen.

The nucleic acid payload then gets transcribed/translated into a Cas9 type of enzyme that looks for a specific sequence belonging to a pathogen. If a match is found the cell gets destroyed. Otherwise, the enzyme degrades and the cell lives on as if nothing happened.

A suitable nucleic acid delivery method could be copied from viruses. The delivery cells could multiply into millions of copies via clonal expansion. In terms of function, this would be a chimeric cell - part viral, part B cell, part macrophage, or similar.

What would it take to make something like this work?
Creative contributions
Know someone who can contribute to this idea? Share it with them on , , or

Add your creative contribution

0 / 200

Added via the text editor

Sign up or

or

Guest sign up

* Indicates a required field

By using this platform you agree to our terms of service and privacy policy.

General comments